Minoxidil
January 2022
in “
Springer eBooks
”
Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Research cited in this study 124
- Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment
- Efficacy and Safety of Oral Minoxidil in Female Androgenetic Alopecia
- Efficacy and Safety of Very-Low-Dose Oral Minoxidil 1.25 mg in Male Androgenetic Alopecia
- Treatment of Male and Female Pattern Hair Loss with Sublingual Minoxidil: A Retrospective Case-Series of 64 Patients
- Low-Dose Oral Minoxidil for Female Pattern Hair Loss: A Unicenter Descriptive Study of 148 Women
- Efficacy and Safety of a New 10% Topical Minoxidil Versus 5% Topical Minoxidil and Placebo in the Treatment of Male Androgenetic Alopecia: A Trichoscopic Evaluation
- Comparative Study Between Mesotherapy and Topical 5% Minoxidil by Dermoscopic Evaluation for Androgenic Alopecia in Males: A Randomized Controlled Trial
- Case Series of Oral Minoxidil for Androgenetic and Traction Alopecia: Tolerability and the Five C’s of Oral Therapy
- Oleic Acid Nanovesicles of Minoxidil for Enhanced Follicular Delivery
- Efficacy of Non-Surgical Treatments for Androgenetic Alopecia: A Systematic Review and Network Meta-Analysis
- Female Pattern Hair Loss: A Pilot Study Investigating Combination Therapy with Low-Dose Oral Minoxidil and Spironolactone
- Evidence-Based Guideline for the Treatment of Androgenetic Alopecia in Women and Men – Short Version
- Alginate-Based Hydrogel Containing Minoxidil/Hydroxypropyl-β-Cyclodextrin Inclusion Complex for Topical Alopecia Treatment
- Treatment of Chronic Telogen Effluvium with Oral Minoxidil: A Retrospective Study
- An Analysis of Gene Expression Data Involving Examination of Signaling Pathways Activation Reveals New Insights into the Mechanism of Action of Minoxidil Topical Foam in Men with Androgenetic Alopecia
- The Effectiveness of Treatments for Androgenetic Alopecia: A Systematic Review and Meta-Analysis
- Solid Effervescent Formulations as a New Approach for Topical Minoxidil Delivery
- Differences in Reproductive Toxicology Between Alopecia Drugs: An Analysis on Adverse Events Among Female and Male Cases
- Minoxidil Topical Treatment May Be More Efficient If Applied on Damp Scalp Compared to Dry Scalp
- Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers
- Effect of Minoxidil Topical Foam on Frontotemporal and Vertex Androgenetic Alopecia in Men: A 104-Week Open-Label Clinical Trial
- Treatment of Permanent Chemotherapy-Induced Alopecia with Low Dose Oral Minoxidil
- A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men
- Similar Response Patterns to Topical Minoxidil Foam 5% in Frontal and Vertex Scalp of Men with Androgenetic Alopecia: A Microarray Analysis
- Minoxidil May Suppress Androgen Receptor-Related Functions
- Long-Pulsed Nd:YAG Laser in the Treatment of Facial Hypertrichosis During Topical Minoxidil Therapy
- Minoxidil Use in Dermatology, Side Effects, and Recent Patents
- Prostaglandin D2 Inhibits Hair Growth and Is Elevated in Bald Scalp of Men with Androgenetic Alopecia
- Intoxication by Minoxidil, Active Ingredient of a Hair Lotion: A Case Report
- A Randomized, Single-Blind Trial of 5% Minoxidil Foam Once Daily Versus 2% Minoxidil Solution Twice Daily in the Treatment of Androgenetic Alopecia in Women
- Minoxidil Activates β-Catenin Pathway in Human Dermal Papilla Cells: A Possible Explanation for Its Anagen Prolongation Effect
- Follicular and Percutaneous Penetration Pathways of Topically Applied Minoxidil Foam
- Intermediate Hair Follicles: A New, More Clinically Relevant Model for Hair Growth Investigations
- In Vitro Skin Permeation of Monoolein Nanoparticles Containing Hydroxypropyl β-Cyclodextrin/Minoxidil Complex
- The Effects of Particle Properties on Nanoparticle Drug Retention and Release in Dynamic Minoxidil Foams
- Hair Follicle Biology and Topical Minoxidil: Possible Mechanisms of Action
- Penetration Enhancer-Containing Vesicles as Carriers for Cutaneous Delivery of Minoxidil
- Relative Uptake of Minoxidil Into Appendages and Stratum Corneum and Permeation Through Human Skin In Vitro
- Biphasic Effects of Minoxidil on the Proliferation and Differentiation of Normal Human Keratinocytes
- Follicular Transport Route: Research Progress and Future Perspectives
- Minoxidil Topical Foam: A New Kid on the Block
- Medical Treatments for Male and Female Pattern Hair Loss
- Human Hair Follicles Contain Two Forms of ATP-Sensitive Potassium Channels, Only One Sensitive to Minoxidil
- A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of a Novel Formulation of 5% Minoxidil Topical Foam Versus Placebo in the Treatment of Androgenetic Alopecia in Men
- Prostaglandin Metabolism in Human Hair Follicle
- Liposomes And Niosomes As Potential Carriers For Dermal Delivery Of Minoxidil
- Is Topical Minoxidil Solution Effective on Androgenetic Alopecia in Routine Daily Practice?
- Efficacy of 5% Minoxidil Versus Combined 5% Minoxidil and 0.01% Tretinoin for Male Pattern Hair Loss
- Effect of Ethosomal Minoxidil on Dermal Delivery and Hair Cycle of C57BL/6 Mice
- Human Hair Growth Ex Vivo Is Correlated With In Vivo Hair Growth: Selective Categorization of Hair Follicles for More Reliable Hair Follicle Organ Culture
- Novel and Established Potassium Channel Openers Stimulate Hair Growth In Vitro: Implications for Their Modes of Action in Hair Follicles
- Penetration Profile of Microspheres in Follicular Targeting of Terminal Hair Follicles
- A Randomized, Placebo-Controlled Trial of 5% and 2% Topical Minoxidil Solutions in the Treatment of Female Pattern Hair Loss
- Effect of Minoxidil on Proliferation and Apoptosis in Dermal Papilla Cells of Human Hair Follicle
- Development and Characterization of Minoxidil-Loaded Liposomal System for Delivery to Pilosebaceous Units
- Minoxidil: Mechanisms of Action on Hair Growth
- Topically Applied Minoxidil May Cause Fetal Malformation: A Case Report
- Topical Minoxidil Counteracts Stress-Induced Hair Growth Inhibition in Mice
- Finasteride Treatment May Not Prevent Telogen Effluvium After Minoxidil Withdrawal
- Safety of Topical Minoxidil Solution: A One-Year, Prospective, Observational Study
- Hypertrichosis in Females Applying Minoxidil Topical Solution and in Normal Controls
- Minoxidil-Containing Dosage Forms: Skin Retention and After-Rinsing Hair-Growth Promotion
- A Randomized Clinical Trial of 5% Topical Minoxidil Versus 2% Topical Minoxidil and Placebo in the Treatment of Androgenetic Alopecia in Men
- Effects of Minoxidil 2% vs. Cyproterone Acetate Treatment on Female Androgenetic Alopecia: A Controlled, 12-Month Randomized Trial
- Pigmented Contact Dermatitis from Topical Minoxidil 5%
- Allergic Contact Dermatitis to Topical Minoxidil Solution: Etiology and Treatment
- Minoxidil-Induced Hair Growth Is Mediated by Adenosine in Cultured Dermal Papilla Cells: Possible Involvement of Sulfonylurea Receptor 2B as a Target of Minoxidil
- Hair Cycle-Dependent Expression of Hepatocyte Growth Factor Activator, Other Proteinases, and Proteinase Inhibitors Correlates with the Expression of Hepatocyte Growth Factor in Rat Hair Follicles
- Changes in Hair Weight and Hair Count in Men with Androgenetic Alopecia After Application of 5% and 2% Topical Minoxidil, Placebo, or No Treatment
- Treatment of Hair Loss
- Minoxidil Increases 17β-Hydroxysteroid Dehydrogenase and 5α-Reductase Activity in Cultured Human Dermal Papilla Cells from Balding Scalp
- Fortnightly Review: Male Pattern Androgenetic Alopecia
- Hair Regrowth
- Minoxidil Upregulates the Expression of Vascular Endothelial Growth Factor in Human Hair Dermal Papilla Cells
- Sulfation of Minoxidil by Multiple Human Cytosolic Sulfotransferases
- Activation of Cytoprotective Prostaglandin Synthase-1 by Minoxidil as a Possible Explanation for Its Hair Growth-Stimulating Effect
- Diffuse Hypertrichosis During Treatment with 5% Topical Minoxidil
- Androgenetic Alopecia in the Female
- Status of Medical Treatment for Androgenetic Alopecia
- Use of Topical Minoxidil Therapy for Androgenetic Alopecia in Women
- Diagnostic and Predictive Value of Horizontal Sections of Scalp Biopsy Specimens in Male Pattern Androgenetic Alopecia
- Enzymatic and Non-Enzymatic Sulfation Mechanisms in the Biological Actions of Minoxidil
- Minoxidil
- Treatment of Female Androgenetic Alopecia with Minoxidil 2%
- Hair Loss With Minoxidil Withdrawal
- Minoxidil Specifically Decreases the Expression of Lysine Hydroxylase in Cultured Human Skin Fibroblasts
- Minoxidil: Inhibition of Proliferation of Keratinocytes In Vitro
- Quantitative Estimation of Hair Growth: Androgenetic Alopecia in Women and the Effect of Minoxidil
- Minoxidil Sulfate Is the Active Metabolite That Stimulates Hair Follicles
- Transdermal Viprostol in the Treatment of Male Pattern Baldness
- Relationship Between Contact Time of Applied Dose and Percutaneous Absorption of Minoxidil From a Topical Solution
- Five-Year Follow-Up of Men with Androgenetic Alopecia Treated with Topical Minoxidil
- Influence of Tretinoin on the Percutaneous Absorption of Minoxidil from an Aqueous Topical Solution
- Telogen Effluvium and Minoxidil
- The Pharmacokinetics of 2.5- to 10-mg Oral Doses of Minoxidil in Healthy Volunteers
- Quantitative Assessment of 2% Topical Minoxidil in the Treatment of Male Pattern Baldness
- Histologic Response to Topically Applied Minoxidil in Male-Pattern Alopecia
- Topical Minoxidil: Cardiac Effects in Bald Men
- Selective Inhibition by Minoxidil of Prostacyclin Production by Cells in Culture
- Alterations in Scalp Blood Flow After the Epicutaneous Application of 3% Minoxidil and 0.1% Hexyl Nicotinate in Alopecia
- Topical Minoxidil Therapy for Androgenetic Alopecia
- Evaluation of Oral Minoxidil in the Treatment of Alopecia Areata
- Topical Minoxidil in Male Pattern Baldness: Effects of Discontinuation of Treatment
- Topical Minoxidil in Early Androgenetic Alopecia
- Safety and Efficacy of Topical Minoxidil in the Management of Androgenetic Alopecia
- Topical Minoxidil Solution (1% and 5%) in the Treatment of Alopecia Areata
- Action of Topical Minoxidil in the Bald Stump-Tailed Macaque
- Topical Minoxidil Does Not Act as an Antiandrogen in the Flank Organ of the Golden Syrian Hamster
- A Falling Out Following Minoxidil: Telogen Effluvium
- Topical Minoxidil for Androgenetic Alopecia: Optimizing the Chance for Success by Appropriate Patient Selection
- Dose-Response Study of Topical Minoxidil in Male Pattern Baldness
- Cyclic Dynamics of Hair Follicles and the Effect of Minoxidil on the Bald Scalps of Stumptailed Macaques
- Topical Minoxidil Therapy in Hereditary Androgenetic Alopecia
- Percutaneous Absorption of Minoxidil in Humans
- Minoxidil Stimulates Cutaneous Blood Flow in Human Balding Scalps: Pharmacodynamics Measured by Laser Doppler Velocimetry and Photopulse Plethysmography
- Sulfation of Minoxidil by Liver Sulfotransferase
- Minoxidil: A Review of Its Pharmacological Properties and Therapeutic Use
- Topical Minoxidil in Alopecia Areata
- Hypertrichosis Due to Minoxidil
- Minoxidil Therapy in Refractory Hypertension: Analysis of 155 Patients
- Minoxidil in Resistant Hypertension
- Minoxidil for Severe Hypertension After Failure of Other Hypotensive Drugs
- Minoxidil Therapy in Children with Severe Hypertension
- Toxicological Studies with the Hypotensive Agent Minoxidil